SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017430
Filing Date
2023-05-15
Accepted
2023-05-15 16:30:51
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1057534
2 ex31-1.htm EX-31.1 18979
3 ex31-2.htm EX-31.2 19004
4 ex32-1.htm EX-32.1 8530
5 ex32-2.htm EX-32.2 8459
  Complete submission text file 0001493152-23-017430.txt   5808643

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ensc-20230331.xsd EX-101.SCH 41220
7 XBRL CALCULATION FILE ensc-20230331_cal.xml EX-101.CAL 49757
8 XBRL DEFINITION FILE ensc-20230331_def.xml EX-101.DEF 201555
9 XBRL LABEL FILE ensc-20230331_lab.xml EX-101.LAB 378127
10 XBRL PRESENTATION FILE ensc-20230331_pre.xml EX-101.PRE 305338
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 850661
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 23923137
SIC: 2834 Pharmaceutical Preparations